Abingworth Bioventures 8 LP
Abingworth · adviser of record: Carlyle Investment Management L.L.C. · 2019 vintage
Abingworth Bioventures 8 LP is a 2019 venture fund managed by Abingworth, with $132mm raised (Form D, amount sold). It reported $230mm in gross assets at year-end 2025, 1.74x its size, against a peak of $466mm in 2020.
- Latest value held
- $230mm year-end 2025
- Peak
- $466mm year-end 2020
- Fund size
- $132mm Form D, amount sold
- Held vs. size
- 1.74x peak 3.53x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $230mm | 1.74x | -3% over 2 yrs |
| 2023 | $238mm | 1.80x | -47% |
| 2022 | $450mm | 3.40x | +3% |
| 2021 | $439mm | 3.32x | -6% |
| 2020 | $466mm | 3.53x | +234% |
| 2019 | $140mm | 1.06x | – |
Other funds from Abingworth
- Abingworth Bioventures VII LP 2016
- Abingworth Clinical CO-Development Fund LP 2015
- Carlyle Venture Partners II 2012
- Abingworth Bioventures V LP 2011
- Abingworth Bioventures VI LP 2011
- Abingworth Bioventures IV LP 2011
- Abingworth Bioventures V CO-Invest Growth Equity Fund LP 2011
- Abingworth Bioventures Iiia LP 2011
- Abingworth Bioventures Iiib LP 2011
- Abingworth Bioventures II Sicav (In Voluntary Liquidation) 2011
- Abingworth Bioventures Iiic LP 2011
- Abingworth Bioventures Iia LP 2011
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-9980486748. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.